![logo](/logos/ROVI.MC.webp)
Laboratorios Farmaceuticos Rovi, S.A.
MSE:ROVI.MC
80.8 (EUR) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Laboratorios Farmaceuticos Rovi, S.A. |
Symbool | ROVI.MC |
Munteenheid | EUR |
Prijs | 80.8 |
Beurswaarde | 4,187,071,271 |
Dividendpercentage | 1.52% |
52-weken bereik | 46.78 - 94.8 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Juan Lopez-Belmonte Encina |
Website | https://www.rovi.es |
An error occurred while fetching data.
Over Laboratorios Farmaceuticos Rovi, S.A.
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company distributes other products that are licensed from other laboratories. Its principal products include Hibor, a low-molecular-weight heparin to prevent and treat venous thromboembolic disease; Enoxaparin
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)